CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Growing availability of medical reimbursements for nerve monitoring
4.1.2. Clinical benefits associated with nerve monitoring procedures
4.1.3. The rise in the ageing population & increase in the incidence of neurological disorders
4.1.4. Rising use of nerve monitoring in trauma cases
4.1.5. Increased clinical studies in the field of nerve monitoring
4.1.6. Emerging markets in developing economies like China
4.2. Market Restraints & Challenges
4.2.1. Limited awareness about nerve monitoring among healthcare professionals
4.2.2. Unstable reimbursement regulations
CHAPTER 5. GLOBAL NERVE MONITORING SYSTEM MARKET – BY PRODUCT
5.1. Nerve Stimulation Electrodes and Probes
5.2. Accessories
5.3. Nerve Monitors
CHAPTER 6. GLOBAL NERVE MONITORING SYSTEM MARKET – BY
TECHNOLOGY
6.1. Electrocorticography
6.2. Evoked Potential
6.3. Electromyography
6.4. Electroencephalography
CHAPTER 7. GLOBAL NERVE MONITORING SYSTEM MARKET - BY
APPLICATION
7.1. ENT Surgery
7.2. Cardiovascular Applications
7.3. Neurosurgery
7.4. Spine Surgery
7.5. Others
CHAPTER 8. GLOBAL NERVE MONITORING SYSTEM MARKET – BY END
USER
8.1. Ambulatory Surgical Centers
8.2. Hospitals and Surgical Centers
8.3. Others
CHAPTER 9. GLOBAL NERVE MONITORING SYSTEM MARKET - BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL NERVE MONITORING SYSTEM MARKET - COMPANY
PROFILES
10.1. Nihon Kohden Corporation
10.2. Natus Medical Incorporated
10.3. Dr. Langer Medical Gmbh
10.4. Medtronic PLC
10.5. Checkpoint Surgical, Inc.
10.6. Xavant Technology Ltd.
10.7. Axon Healthcare Ltd.
10.8. Erbe Elektromedizin GmbH
10.9. The Magstim Company Limited.
10.10. Ems Handels Gesellschaft GmbH
10.11. Neurovision Medical Products, Inc.
10.12. Inomed Medizintechnik GmbH
10.13. Deymed Diagnostics Inc.
10.14. Bovie Medical Corporation
CHAPTER 11. GLOBAL NERVE MONITORING SYSTEM MARKET –
COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
